Presspart, a division of the Heitkamp & Thumann Group, has launched a new sub-micron plasma process for coating and treating the internal surfaces of pMDI canisters. Presspart Plasma Coating and Presspart Plasma Treatment offer solutions for problems with deposition of drug suspension on the canister wall and can also improve drug stability performance.

Deposition of the active content of a drug formulation on canister surfaces is a long-standing problem with some MDI products. This ultimately leads to a reduction in the drug content in the formulation, resulting in the patient receiving less than the prescribed dose. Presspart’s Plasma Technology can improve the surface energy performance of a MDI canister, thus reducing deposition. It can also improve the stability of some formulations where interactions with the aluminium substrate can lead to product degradation and reduced shelf
life.

Presspart’s Plasma Technology specifically meets the requirements of the pMDI market and has scaled-up the process to meet the high volume demands. Julian Hemy, Director of Global Sales, comments, “We’re very excited to be launching the Presspart Plasma Technology. Plasma-processed canisters will make a big difference to the performance and stability of drugs delivered through pMDIs. We are looking forward to presenting this new technology at the Inhaled Drug Delivery conference in London on the 9th and 10th of November.”

MDI cans

About Presspart

About Presspart Drawing on 42 years of success, Presspart Manufacturing Ltd has developed in to a World-leader of bespoke deep-drawn and injection moulded components, with manufacturing plants located across the Globe. Presspart's ability to offer customers a unique service in toolmaking, design and development skills has been the foundation for more than four decades of successful … read more

Inhalation Product Technology Centre from Presspart

Inhalation Product Technology Centre (IPTC)

Inhalation Product Technology Centre (IPTC) from Presspart Supporting the strategic projects of Presspart and our customers Here at Presspart Manufacturing, we have further expanded our research and development capabilities with the introduction of an Inhalation Product Technology Centre (IPTC). As the world’s leading manufacturer of components for metered dose inhalers, including MDI canisters … read more

What You Need to Know About Asthma (Infographic)

Asthma is one of the most common conditions that affects people in the UK - and we're proud to be a part of the fight against this often debilitating disease. But how widespread is asthma? What are the facts? … read more

H&T Presspart and Hovione Technology Enter Dry Powder Inhalation Partnership

H&T Presspart and Hovione Technology Enter Dry Powder Inhalation Partnership Dry Powder Inhaler unveiled at Respiratory Drug Delivery Conference Europe H&T Presspart, the world’s leading manufacturer of components for metered dose inhalers (MDIs), today announced a collaborative partnership with Hovione Technology, supporting a strategic plan to expand its portfolio of novel drug … read more

© Copyright Presspart Manufacturing Ltd. All Rights Reserved | Whitebirk Ind. Est. Blackburn, Lancashire, BB1 5RF United Kingdom Tel: +44 (0)1254 582233 | Site: www.imageworksltd.com
Privacy Policy | Imprint